NEW YORK (GenomeWeb News) - InforSense said today that it has extended and expanded a license agreement with Cambridge University’s Department of Pathology for four of its software platforms.
Under the agreement, Cambridge has extended its license for the company’s InforSense and BioSense products, and its GenSense and Genome Wide Association Study modules.
Financial terms of the agreement were not released.